Wyeth Consumer Healthcare is reviewing its estimated £8m advertising business for painkilling drug Anadin.Incumbent DDB London, which has held the account for almost three years, has decided not to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results